Cite
MLA Citation
Alexander M.M. Eggermont et al.. “Prognostic and predictive value of AJCC-8 staging in the phase III EORTC1325/KEYNOTE-054 trial of pembrolizumab vs placebo in resected high-risk stage III melanoma.” European journal of cancer, vol. 116, 2019, pp. 148–157. http://access.bl.uk/ark:/81055/vdc_100086505541.0x000022